AHCO vs ALB · P/E 16, rev $1.42B vs rev $1.74B
Adapthealth Corp (AHCO) versus Albemarle Corp (ALB) — a side-by-side from cached financials, not a winner call.
Adapthealth Corp (AHCO) is a medical devices company listed on US.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Latest reported AHCO revenue for 2026-06-30 was $1.42B. Net income was -$150.0M. Revenue was up 73.2% from 2026-03-31 to 2026-06-30. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. ALB currently screens at market cap $8.00B.
Not investment advice. Open the AHCO and ALB stock pages for the full models.
Not investment advice.